Biotechnology & Life Sciences Global On demand · 24-48h

Global DNA Extraction Services Market Strategic Research Report

Global DNA Extraction Services Market Strategic Research Rep…
$3,500 USD
Market Research Reports
Strategic Research Report
Global DNA Extraction Services Market
$7112025
8.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Plant DNA Extraction Services, Animal DNA Extraction Services, Microbial DNA Extraction Services, Others

By Application: Polymerase Chain Reaction (PCR), Sequencing, Cloning, Genotyping

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Eurofins Genomics, Azenta Life Sciences, LGC Biosearch Technologies, Labcorp, REPROCELL, BGI Genomics, Novogene, LC Sciences, CD Genomics, GenScript, Source BioScience, Microsynth, Zymo Research, FASMAC, Takara Bio

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 107 pages
Market size 2025
$711
Million USD
Forecast CAGR
8.1%
2025-2032
Forecast 2032
$1226.4
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global DNA Extraction Services market size is predicted to grow from US$ 711 million in 2025 to US$ 1,227 million in 2032; it is expected to grow at a CAGR of 8.1% from 2026 to 2032.

DNA extraction services involve the processes and techniques used to isolate DNA from various biological samples, such as blood, saliva, tissues, or other cell types. These services are crucial in various fields, including research, clinical diagnostics, forensics, and genetic testing.DNA Extraction Services refer to outsourced services provided by third-party laboratories or genomics service providers, encompassing the extraction, purification, quality assessment, and delivery of DNA from client samples. These services typically involve the isolation of genomic DNA, cfDNA, microbial DNA, or high-molecular-weight DNA from a wide range of materials—including blood, saliva, swabs, tissues, FFPE samples, cells, plants, animals, microorganisms, soil, feces, food products, and environmental samples. Furthermore, these services provide support for concentration determination, purity analysis, integrity assessment, as well as downstream applications such as PCR, sequencing, genotyping, microarray analysis, or long-term sample storage.

DNA extraction serves as a foundational step for NGS, Sanger sequencing, PCR, genotyping, pathogen detection, and molecular diagnostics. By outsourcing the extraction process to specialized laboratories, clients can minimize sample loss, increase throughput, and shorten project turnaround times. Research institutions, CROs, and sequencing service providers are increasingly adopting automated extraction platforms to process high-volume sample batches, thereby enhancing consistency, reducing manual errors, and meeting the large-scale sample requirements inherent in cohort studies, agricultural breeding, microbiome research, forensics, and preclinical studies. Market demand is currently expanding beyond standard gDNA extraction to encompass more complex sample types and scenarios—including FFPE tissues, cfDNA, ctDNA, single cells, microbial samples, soil, feces, plant tissues, and food samples. GENEWIZ notes that its whole-genome sequencing services support DNA extraction for over 30 standard sample types, as well as hundreds of customized sample types; similarly, LGC Biosearch Technologies emphasizes its capability to develop both standard and customized nucleic acid extraction protocols tailored to a wide variety of starting materials and sample volumes.

This report presents a comprehensive overview of the global DNA Extraction Services market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Plant DNA Extraction Services
  • Animal DNA Extraction Services
  • Microbial DNA Extraction Services
  • Others

Segment by DNA Type

  • Plant DNA Extraction Services
  • Animal DNA Extraction Services
  • Microbial DNA Extraction Services
  • Others

Segment by Technology

  • Magnetic Bead-Based DNA Extraction Services
  • Silica Column-Based DNA Extraction Services
  • Organic Solvent-Based DNA Extraction Services
  • Precipitation-Based DNA Extraction Services
  • Others

Segment by Application

  • Polymerase Chain Reaction (PCR)
  • Sequencing
  • Cloning
  • Genotyping

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global DNA Extraction Services market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Polymerase Chain Reaction (PCR), Sequencing, Cloning evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global DNA Extraction Services Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$711
2025
Forecast
$1226.4
2032
CAGR
8.1%
2025–2032
リージョン
5
global
Key companies
Eurofins GenomicsAzenta Life SciencesLGC Biosearch TechnologiesLabcorpREPROCELLBGI GenomicsNovogeneLC Sciences
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Plant DNA Extraction ServicesAnimal DNA Extraction ServicesMicrobial DNA Extraction ServicesOthers
By Application
Polymerase Chain Reaction (PCR)SequencingCloningGenotyping

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Plant DNA Extraction Services
  • 3.1.3 Animal DNA Extraction Services
  • 3.1.4 Microbial DNA Extraction Services
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Polymerase Chain Reaction (PCR)
  • 4.1.3 Sequencing
  • 4.1.4 Cloning
  • 4.1.5 Genotyping
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Eurofins Genomics
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Azenta Life Sciences
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 LGC Biosearch Technologies
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Labcorp
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 REPROCELL
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 BGI Genomics
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Novogene
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 LC Sciences
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 CD Genomics
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 GenScript
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Source BioScience
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Microsynth
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Zymo Research
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 FASMAC
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Takara Bio
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global DNA Extraction Services market?
The global DNA Extraction Services market is estimated at US$ 711 million in 2025 (base year) and is projected to reach US$ 1.23 billion by 2032.
What is the forecast CAGR for the DNA Extraction Services market?
The market is expected to grow at a CAGR of 8.1% from 2026 to 2032, expanding from US$ 711 million in 2025 to US$ 1.23 billion in 2032, roughly 1.7 times its base-year value.
What is DNA Extraction Services?
DNA extraction services involve the processes and techniques used to isolate DNA from various biological samples, such as blood, saliva, tissues, or other cell types. These services are crucial in various fields, including research, clinical diagnostics, forensics, and genetic testing.DNA Extraction Services refer to outsourced services provided by third-party laboratories or genomics service providers, encompassing the extraction, purification, quality assessment, and delivery of DNA from client samples.
What are the main segments of the DNA Extraction Services market by type?
By type, the market is segmented into Plant DNA Extraction Services, Animal DNA Extraction Services, Microbial DNA Extraction Services and Others.
Which applications drive demand in the DNA Extraction Services market?
Key applications covered include Polymerase Chain Reaction (PCR), Sequencing, Cloning and Genotyping.
Who are the key players in the DNA Extraction Services market?
Key players profiled include Eurofins Genomics, Azenta Life Sciences, LGC Biosearch Technologies, Labcorp, REPROCELL, BGI Genomics, Novogene and LC Sciences, among 15 companies covered in total.
Which regions and countries are covered for DNA Extraction Services?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the DNA Extraction Services market report?
The report is intended for manufacturers and solution providers, distributors and end users in Polymerase Chain Reaction (PCR), Sequencing and Cloning, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the DNA Extraction Services market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.